Literature DB >> 33772212

Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases.

Edaise M da Silva1, Daniel J Fix1,2, Ana Paula Martins Sebastiao1,3, Pier Selenica1, Lorenzo Ferrando1,4, Sarah H Kim5, Anthe Stylianou5, Arnaud Da Cruz Paula5, Fresia Pareja1, Evan S Smith5, Ahmet Zehir1, Jason A Konner6, Karen Cadoo6, Jorge S Reis-Filho1, Nadeem R Abu-Rustum5, Jennifer J Mueller5, Britta Weigelt7, Kay J Park8.   

Abstract

Mesonephric carcinoma of the cervix is a rare tumor derived from Wolffian remnants. Mesonephric-like carcinomas of the ovary and endometrium, while morphologically similar, do not have obvious Wolffian derivation. Here, we sought to characterize the repertoire of genetic alterations in primary mesonephric and mesonephric-like carcinomas, in the distinct histologic components of mixed cases, as well as in matched primary tumors and metastases. DNA from microdissected tumor and normal tissue from mesonephric carcinomas (cervix, n = 8) and mesonephric-like carcinomas (ovarian n = 15, endometrial n = 13) were subjected to sequencing targeting 468 cancer-related genes. The histologically distinct components of four cases with mixed histology and four primary tumors and their matched metastases were microdissected and analyzed separately. Mesonephric-like carcinomas were underpinned by somatic KRAS mutations (25/28, 89%) akin to mesonephric carcinomas (8/8, 100%), but also harbored genetic alterations more frequently reported in Müllerian tumors. Mesonephric-like carcinomas that lacked KRAS mutations harbored NRAS (n = 2, ovary) or BRAF (n = 1, endometrium) hotspot mutations. PIK3CA mutations were identified in both mesonephric-like (8/28, 28%) and mesonephric carcinomas (2/8, 25%). Only mesonephric-like tumors harbored CTNNB1 hotspot (4/28, 14%) and PTEN (3/13, 23%) mutations. Copy number analysis revealed frequent gains of chromosomes 1q and 10 in both mesonephric (87% 1q; 50% chromosome 10) and mesonephric-like tumors (89% 1q; 43% chromosome 10). Chromosome 12 gains were more frequent in ovarian mesonephric-like carcinomas, and losses of chromosome 9 were more frequent in mesonephric than in mesonephric-like carcinomas (both p = 0.01, Fisher's exact test). The histologically distinct components of four mixed cases were molecularly related and shared similar patterns of genetic alterations. The progression from primary to metastatic lesions involved the acquisition of additional mutations, and/or shifts from subclonal to clonal mutations. Our findings suggest that mesonephric-like carcinomas are derived from a Müllerian substrate with differentiation along Wolffian/mesonephric lines.
© 2021. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.

Entities:  

Mesh:

Year:  2021        PMID: 33772212      PMCID: PMC8343944          DOI: 10.1038/s41379-021-00799-6

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  52 in total

1.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.

Authors:  Ronglai Shen; Venkatraman E Seshan
Journal:  Nucleic Acids Res       Date:  2016-06-07       Impact factor: 16.971

2.  Mesonephric adenocarcinoma of the vagina masquerading as a suburethral cyst.

Authors:  Samar Shoeir; Aswini Aparna Balachandran; Jayson Wang; Abdul H Sultan
Journal:  BMJ Case Rep       Date:  2018-07-03

3.  A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium.

Authors:  David L Kolin; Danielle C Costigan; Fei Dong; Marisa R Nucci; Brooke E Howitt
Journal:  Am J Surg Pathol       Date:  2019-03       Impact factor: 6.394

Review 4.  Non-diethylstilbestrol exposed vaginal adenocarcinoma in young patients associated with unilateral renal agenesis: two case reports and literature review.

Authors:  V Plesinac-Karapandzic; S Stojanovic Rundic; R Jankovic; M Nadrljanski; Z Milovanovic; A Tomasevic; N Perisie Jeremic
Journal:  Eur J Gynaecol Oncol       Date:  2017       Impact factor: 0.196

5.  Accelerating Discovery of Functional Mutant Alleles in Cancer.

Authors:  Matthew T Chang; Tripti Shrestha Bhattarai; Alison M Schram; Craig M Bielski; Mark T A Donoghue; Philip Jonsson; Debyani Chakravarty; Sarah Phillips; Cyriac Kandoth; Alexander Penson; Alexander Gorelick; Tambudzai Shamu; Swati Patel; Christopher Harris; JianJiong Gao; Selcuk Onur Sumer; Ritika Kundra; Pedram Razavi; Bob T Li; Dalicia N Reales; Nicholas D Socci; Gowtham Jayakumaran; Ahmet Zehir; Ryma Benayed; Maria E Arcila; Sarat Chandarlapaty; Marc Ladanyi; Nikolaus Schultz; José Baselga; Michael F Berger; Neal Rosen; David B Solit; David M Hyman; Barry S Taylor
Journal:  Cancer Discov       Date:  2017-12-15       Impact factor: 39.397

6.  Absolute quantification of somatic DNA alterations in human cancer.

Authors:  Scott L Carter; Kristian Cibulskis; Elena Helman; Aaron McKenna; Hui Shen; Travis Zack; Peter W Laird; Robert C Onofrio; Wendy Winckler; Barbara A Weir; Rameen Beroukhim; David Pellman; Douglas A Levine; Eric S Lander; Matthew Meyerson; Gad Getz
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

7.  Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.

Authors:  Mitsutake Yano; Daisuke Shintani; Tomomi Katoh; Mei Hamada; Kozue Ito; Eito Kozawa; Kosei Hasegawa; Masanori Yasuda
Journal:  Diagn Pathol       Date:  2019-06-07       Impact factor: 2.644

8.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

Authors:  Kristian Cibulskis; Michael S Lawrence; Scott L Carter; Andrey Sivachenko; David Jaffe; Carrie Sougnez; Stacey Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz
Journal:  Nat Biotechnol       Date:  2013-02-10       Impact factor: 54.908

9.  Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.

Authors:  Pavel Dundr; Mária Gregová; Kristýna Němejcová; Michaela Bártů; Nikola Hájková; Jan Hojný; Ivana Stružinská; Daniela Fischerová
Journal:  Diagn Pathol       Date:  2020-07-21       Impact factor: 2.644

10.  Genome-wide somatic variant calling using localized colored de Bruijn graphs.

Authors:  Giuseppe Narzisi; André Corvelo; Kanika Arora; Ewa A Bergmann; Minita Shah; Rajeeva Musunuri; Anne-Katrin Emde; Nicolas Robine; Vladimir Vacic; Michael C Zody
Journal:  Commun Biol       Date:  2018-03-22
View more
  10 in total

1.  Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.

Authors:  Tianshi Ma; Mengyu Chai; Huafeng Shou; Guoqing Ru; Ming Zhao
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

2.  Mucinous Tumor Coexisting With Mesonephric-like Proliferation/Tumor in the Ovary: A Novel Association.

Authors:  Neshat Nilforoushan; Lian Liu; Gloria Cheang; Amy C Sui; John Andersen; Brian S Finkelman; Ying Liu; Niloofar Nasseri-Nik; Russell Vang; Brigitte M Ronnett; Wei Song; Deyin Xing
Journal:  Am J Surg Pathol       Date:  2022-04-12       Impact factor: 6.298

3.  Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.

Authors:  Hyun Hee Koh; Eunhyang Park; Hyun-Soo Kim
Journal:  Diagnostics (Basel)       Date:  2022-01-27

4.  ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.

Authors:  Britta Weigelt; Sarah Chiang; Kimberly Dessources; Kathryn M Miller; Elizabeth Kertowidjojo; Arnaud Da Cruz Paula; Youran Zou; Pier Selenica; Edaise M da Silva; Ryma Benayed; Charles W Ashley; Nadeem R Abu-Rustum; Snjezana Dogan; Robert A Soslow; Martee L Hensley
Journal:  Mod Pathol       Date:  2021-12-27       Impact factor: 8.209

5.  Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma.

Authors:  Sherry Shen; Maria M Rubinstein; Kay J Park; Jason A Konner; Vicky Makker
Journal:  Gynecol Oncol Rep       Date:  2021-08-08

6.  Somatic mutation analysis of Mesonephric-Like adenocarcinoma and associated putative precursor Lesions: Insight into pathogenesis and potential molecular treatment targets.

Authors:  Elizabeth Arslanian; Kamaljeet Singh; C James Sung; M Ruhul Quddus
Journal:  Gynecol Oncol Rep       Date:  2022-07-19

7.  Genomic landscape of endometrial carcinomas of no specific molecular profile.

Authors:  Amir Momeni-Boroujeni; Bastien Nguyen; Chad M Vanderbilt; Marc Ladanyi; Nadeem R Abu-Rustum; Carol Aghajanian; Lora H Ellenson; Britta Weigelt; Robert A Soslow
Journal:  Mod Pathol       Date:  2022-04-01       Impact factor: 8.209

8.  Mucinous Borderline Tumor Associated with Mesonephric-like Proliferation: Further Evidence for a Possible New Origin of Ovarian Mucinous Neoplasms.

Authors:  Jie Zhang; Yuling Dong; Xiaoqiu Zhou; Brian S Finkelman; Deyin Xing
Journal:  Diagnostics (Basel)       Date:  2022-08-05

9.  Mesonephric Adenocarcinoma of the Vagina Harboring TP53 Mutation.

Authors:  Hyunjee Lee; Hyunjin Kim; Hyun-Soo Kim
Journal:  Diagnostics (Basel)       Date:  2022-01-05

Review 10.  The Evolution of Ovarian Carcinoma Subclassification.

Authors:  Martin Köbel; Eun Young Kang
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.